Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ste14 protein, S cerevisiae

Known as: YDR410C protein, S cerevisiae, isoprenylcysteine carboxylmethyltransferase Ste14, S cerevisiae 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cancer stem cells possess the capacity for self-renewal and resistance to chemotherapy. It is therefore crucial to understand the… Expand
  • figure 1
  • figure 4
  • figure 7
Is this relevant?
2019
2019
Blockade of Ras activity by inhibiting its post-translational methylation catalysed by isoprenylcysteine… Expand
Is this relevant?
2019
2019
Development of chemo-resistance in nasopharyngeal carcinoma (NPC) poses the therapeutic challenge and its mechanisms are still… Expand
Is this relevant?
2017
2017
Despite extensive effort, there has been limited progress in the development of direct RAS inhibitors. Targeting… Expand
  • figure 1
  • figure 2
Is this relevant?
2017
2017
Pancreatic cancer remains one of the most difficult to treat human cancers despite recent advances in targeted therapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Isoprenylcysteine carboxylmethyltransferase (ICMT) catalyzes the post-translational modification of RAB GTPases that contain C… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2016
2016
Despite the success of BCR-ABL1 tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML), resistance to… Expand
Is this relevant?
2013
2013
Inhibition of isoprenylcysteine Carboxylmethyltransferase (ICMT) is of particular interest as a potential target for the… Expand
Is this relevant?
2011
2011
Numerous proteins involved in diverse aspects of cell biology undergo a process of post-translational modification termed… Expand
Is this relevant?